People · Operator
Named in public records as an officer, director or promoter · active 2008–2015 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Catabasis Pharmaceuticals Inc | — | Pharmaceuticals | Series D+ | $349.6M | $3.3B | 2008 |
| Selventa, Inc. | — | Other Health Care | Series A | $5.5M | $100.2M | 2010 |
| Adheron Therapeutics, Inc. | — | Pharmaceuticals | Seed | $1.5M | $57.1M | 2015 |
Chris Thomajan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Thomajan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ron Laufer | 2 | 3 |
| Michael Ross | 1 | 18 |
| Michael Grey | 1 | 10 |
| Noubar Afeyan | 1 | 9 |
| Rajeev Dadoo | 1 | 7 |
| Mitchell Bloom | 1 | 6 |
| Nicholas Galakatos | 1 | 6 |
| Arnold Levine | 1 | 4 |
| Jeffrey Leiden | 1 | 4 |
| Nicholas C. Galakatos | 1 | 3 |
| Sean McCarthy | 1 | 3 |
| David De Graaf | 1 | 3 |
| Hari Kumar | 1 | 3 |
| Michael C. Ross | 1 | 3 |
| Jim Matheson | 1 | 2 |
| Doug Onsi | 1 | 2 |
| Michael Pavia | 1 | 2 |
| Isai Peimer | 1 | 2 |
| Joanne T. Beck | 1 | 2 |
| Michael D. Kishbauch | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.